“When Huntington’s Disease Comes, It Comes”
Gabby McNary still remembers the day she tested positive for Huntington’s disease. “It was January of 2015,” she explains. "After a year of genetic testing, my neurologist told me that my results were in."
Why Representation Matters in Clinical Trials
Clinical trials are vital in preventing, detecting, and treating disease. Diversity is important in making sure we know all we can about a treatment’s benefits and risks, and the people enrolled in a clinical trial should represent the types of people who are likely to use the therapy.
Patients Have Power Writing Contest Winners
The Clara team is proud to announce the winners of the Patients Have Power Writing Contest. Our judges were extremely impressed with the entries we received making the final decision a difficult one.
COVID-19 & Decentralization of Clinical Trials In 2020
In a recent report into how the global COVID-19 pandemic is shifting the way clinical...
Fasenra (Benralizumab) | How It Works, Dosing, Cost & Medicare Coverage
Fasenra (Benralizumab) is a maintenance treatment given to people with eosinophilic asthma. It is not...
Patients Have Power Twitter Chat: Fears, Hopes & Realities for Chronic Illness Patients During COVID-19
This year has been incredibly difficult for many people due to the global pandemic. From...
What Is Ear Eczema? - Symptoms, Causes and Treatments
Eczema (Also known as Atopic Dermatitis) is the name for a group of conditions that...
